XBiotech (XBIT) Competitors $4.56 +0.06 (+1.33%) (As of 12/24/2024 05:19 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends XBIT vs. ETNB, PLRX, RLAY, AVXL, KROS, KURA, IMNM, TYRA, ERAS, and CRONShould you be buying XBiotech stock or one of its competitors? The main competitors of XBiotech include 89bio (ETNB), Pliant Therapeutics (PLRX), Relay Therapeutics (RLAY), Anavex Life Sciences (AVXL), Keros Therapeutics (KROS), Kura Oncology (KURA), Immunome (IMNM), Tyra Biosciences (TYRA), Erasca (ERAS), and Cronos Group (CRON). These companies are all part of the "pharmaceutical products" industry. XBiotech vs. 89bio Pliant Therapeutics Relay Therapeutics Anavex Life Sciences Keros Therapeutics Kura Oncology Immunome Tyra Biosciences Erasca Cronos Group XBiotech (NASDAQ:XBIT) and 89bio (NASDAQ:ETNB) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, community ranking, analyst recommendations and profitability. Do institutionals & insiders hold more shares of XBIT or ETNB? 55.7% of XBiotech shares are owned by institutional investors. 33.1% of XBiotech shares are owned by company insiders. Comparatively, 2.8% of 89bio shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Do analysts recommend XBIT or ETNB? 89bio has a consensus target price of $30.33, indicating a potential upside of 282.03%. Given 89bio's stronger consensus rating and higher probable upside, analysts plainly believe 89bio is more favorable than XBiotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score XBiotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.0089bio 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.86 Which has higher earnings and valuation, XBIT or ETNB? XBiotech has higher revenue and earnings than 89bio. XBiotech is trading at a lower price-to-earnings ratio than 89bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioXBiotech$4.01M34.66-$24.56M-$1.08-4.2289bioN/AN/A-$142.19M-$2.91-2.73 Does the media prefer XBIT or ETNB? In the previous week, 89bio had 1 more articles in the media than XBiotech. MarketBeat recorded 7 mentions for 89bio and 6 mentions for XBiotech. 89bio's average media sentiment score of 0.48 beat XBiotech's score of 0.01 indicating that 89bio is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment XBiotech 0 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral 89bio 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Does the MarketBeat Community believe in XBIT or ETNB? XBiotech received 209 more outperform votes than 89bio when rated by MarketBeat users. Likewise, 69.98% of users gave XBiotech an outperform vote while only 64.67% of users gave 89bio an outperform vote. CompanyUnderperformOutperformXBiotechOutperform Votes31769.98% Underperform Votes13630.02% 89bioOutperform Votes10864.67% Underperform Votes5935.33% Is XBIT or ETNB more profitable? XBiotech's return on equity of -15.99% beat 89bio's return on equity.Company Net Margins Return on Equity Return on Assets XBiotechN/A -15.99% -14.85% 89bio N/A -59.58%-52.21% Which has more risk & volatility, XBIT or ETNB? XBiotech has a beta of 1.41, meaning that its share price is 41% more volatile than the S&P 500. Comparatively, 89bio has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500. SummaryXBiotech beats 89bio on 10 of the 17 factors compared between the two stocks. Ad Insiders ExposedMysterious drone activity triggers massive 1,366% surgeIf mysterious drones buzzing over the East Coast weren’t on your radar this year, you’re not alone. But here’s what you really need to know: An early warning signal tipped off investors to a tiny drone stock that later skyrocketed 1,366%.👉 Click here now to see how this signal works. Get XBiotech News Delivered to You Automatically Sign up to receive the latest news and ratings for XBIT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XBIT vs. The Competition Export to ExcelMetricXBiotechPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$139.00M$6.70B$5.22B$9.27BDividend YieldN/A3.00%5.12%4.30%P/E Ratio-4.2210.5887.5817.28Price / Sales34.66195.781,166.69119.73Price / CashN/A57.1543.2337.83Price / Book0.635.164.834.93Net Income-$24.56M$151.58M$120.46M$225.34M7 Day Performance-32.34%-0.64%-0.26%1.13%1 Month Performance-33.24%-3.02%15.99%2.76%1 Year Performance16.33%8.81%30.22%16.90% XBiotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XBITXBiotech0.8484 of 5 stars$4.56+1.3%N/A+16.3%$139.00M$4.01M-4.22100News CoverageGap DownETNB89bio1.8468 of 5 stars$7.91+2.9%$30.33+283.5%-27.2%$839.46MN/A-2.6440PLRXPliant Therapeutics3.797 of 5 stars$13.77+3.5%$40.50+194.1%-21.9%$837.90M$1.58M0.0090RLAYRelay Therapeutics2.301 of 5 stars$4.80+1.9%$20.50+327.1%-62.4%$803.42M$25.55M-1.80304AVXLAnavex Life Sciences3.6129 of 5 stars$9.23+9.1%$43.00+365.9%+21.5%$782.70MN/A-18.5440Earnings ReportAnalyst ForecastNews CoverageGap UpKROSKeros Therapeutics3.3774 of 5 stars$19.31+2.5%$81.33+321.2%-56.3%$782.19M$651,000.00-3.61100Analyst ForecastHigh Trading VolumeKURAKura Oncology4.4825 of 5 stars$9.98+3.6%$29.38+194.3%-35.3%$776.05MN/A-4.08142IMNMImmunome2.7301 of 5 stars$12.32-2.1%$28.83+134.0%+17.4%$768.98M$10.13M-1.5540Positive NewsTYRATyra Biosciences2.129 of 5 stars$15.06+0.8%$31.00+105.8%+4.8%$762.04MN/A-9.2820ERASErasca2.064 of 5 stars$2.62+2.3%$5.90+125.2%+21.8%$740.75MN/A-3.08126CRONCronos Group1.8624 of 5 stars$1.92-0.3%$3.00+55.9%+0.5%$735.85M$87.24M-15.19356 Related Companies and Tools Related Companies ETNB Competitors PLRX Competitors RLAY Competitors AVXL Competitors KROS Competitors KURA Competitors IMNM Competitors TYRA Competitors ERAS Competitors CRON Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:XBIT) was last updated on 12/25/2024 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XBiotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share XBiotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XBIT Stock Alerts